167 related articles for article (PubMed ID: 12922098)
1. Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65.
Baek KM; Ko SY; Lee M; Lee JS; Kim JO; Ko HJ; Lee JW; Lee SH; Cho SN; Kang CY
Vaccine; 2003 Sep; 21(25-26):3684-9. PubMed ID: 12922098
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
4. Th1 polarized response induced by intramuscular DNA-HSP65 immunization is preserved in experimental atherosclerosis.
Fonseca DM; Bonato VL; Silva CL; Sartori A
Braz J Med Biol Res; 2007 Nov; 40(11):1495-504. PubMed ID: 17934646
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
8. Vaccine adjuvant: it makes the difference.
Lima KM; dos Santos SA; Rodrigues JM; Silva CL
Vaccine; 2004 Jun; 22(19):2374-9. PubMed ID: 15193397
[TBL] [Abstract][Full Text] [Related]
9. Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles.
Johansen P; Raynaud C; Yang M; Colston MJ; Tascon RE; Lowrie DB
Immunol Lett; 2003 Dec; 90(2-3):81-5. PubMed ID: 14687708
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.
Grover A; Troudt J; Foster C; Basaraba R; Izzo A
Immunology; 2014 May; 142(1):111-23. PubMed ID: 24350616
[TBL] [Abstract][Full Text] [Related]
11. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
12. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
Xu J; Xu W; Chen X; Zhao D; Wang Y
Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
[TBL] [Abstract][Full Text] [Related]
13. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
Li H; Li R; Zhong S; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):291-4. PubMed ID: 17428378
[TBL] [Abstract][Full Text] [Related]
14. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
Okada M; Kita Y; Nakajima T; Hashimoto S; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC
Hum Vaccin Immunother; 2013 Mar; 9(3):515-25. PubMed ID: 23249543
[TBL] [Abstract][Full Text] [Related]
15. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
16. Construction of a eukaryotic expression system of HSP65 gene from Mycobacterium tuberculosis, and anti-HSP65 IgG produced in mice.
Ju W; Liu J; Xiao W; Liu M; Qu X
J Med Microbiol; 2005 Jan; 54(Pt 1):3-6. PubMed ID: 15591248
[TBL] [Abstract][Full Text] [Related]
17. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on the immunogenicity between Hsp70 DNA vaccine and Hsp65 DNA vaccine in human Mycobacterium tuberculosis.
Dai W; Huang H; Yuan Y; Hu J; Huangfu Y
J Tongji Med Univ; 2001; 21(3):181-3. PubMed ID: 12539570
[TBL] [Abstract][Full Text] [Related]
19. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
[TBL] [Abstract][Full Text] [Related]
20. Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.
Wang QM; Sun SH; Hu ZL; Yin M; Xiao CJ; Zhang JC
Vaccine; 2004 Sep; 22(27-28):3622-7. PubMed ID: 15315841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
